At Hearing, Warren Highlights Impact of Inflation Reduction Act on Massachusetts, Debunks Big Pharma's Claims that Medicare Drug Price Negotiation is Bad for Innovation
September 18, 2024
September 18, 2024
WASHINGTON, Sept. 18 -- Sen. Elizabeth Warren, D-Massachusetts, issued the following news release:
At a hearing of the Senate Finance Committee, Senator Warren highlighted significant health care savings for seniors in Massachusetts as a result of the Inflation Reduction Act (IRA), which Congress passed with zero Republican votes, and debunked claims that allowing Medicare to negotiate drug prices will harm innovation and investment in the pharmaceutical industry.
In r . . .
At a hearing of the Senate Finance Committee, Senator Warren highlighted significant health care savings for seniors in Massachusetts as a result of the Inflation Reduction Act (IRA), which Congress passed with zero Republican votes, and debunked claims that allowing Medicare to negotiate drug prices will harm innovation and investment in the pharmaceutical industry.
In r . . .